BLGO · Biolargo, Inc.
$0.09
-0.01 (-5.26%)
At close · Sep 3
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“The foregoing factors raise substantial doubt about our ability to continue as a going concern, unless we are able to increase revenues, generate cash from operations, and/or generate cash from financing activities.”View the 10-Q filed Aug 14, 2026
Market Cap
$32.87M
Shares
328.73M
BLGO metrics
59 of 114 screener metrics currently available.
Market overview
2 metricsShare price
$0.09
Market cap
$32.87M
Price action
19 metricsPrice change (1W)
-13.6%
Price change (30D)
-13.6%
Price change (3M)
-20.8%
Price change (6M)
-47.2%
Price change (YTD)
-47.2%
Price change (1Y)
-56.8%
Trailing year
Price change (5Y)
-50.0%
52-week high
$0.23
52-week low
$0.08
Change from 52-week high
-58.7%
Change from 52-week low
+13.9%
Annualized volatility
91.2%
Beta
0.3
RSI (14D)
43.8
Price vs SMA 50
-11.4%
Price vs SMA 200
-35.7%
Avg volume (3M)
384,919
Relative volume
2.4
Average dollar volume
$43,113
Company
3 metricsSector
Basic Materials
Industry
Specialty Chemicals
Shares outstanding
328.73M
Valuation
12 metricsP / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
8.1×
reciprocal yield 12.4%
P / book
—
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-57.2%
Historical valuation
8 metricsP / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
5.6×
reciprocal yield 17.8%
EV / revenue historical average (5Y)
10.7×
reciprocal yield 9.3%
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—
Dividends & buybacks
7 metricsDividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—
Earnings calendar
2 metricsNext earnings
—
Last earnings
—
Profitability
9 metricsGross margin
39.9%
Operating margin
-444.0%
Trailing 12 months
Net margin
-460.3%
Gross profit (TTM)
$1.63M
Operating profit (TTM)
−$18.12M
Net income (TTM)
−$18.79M
Trailing 12 months
Diluted EPS (TTM)
—
FCF margin
—
Effective tax rate
—
Growth
11 metricsRevenue growth YoY
-55.1%
Year over year
Net income growth YoY
—
Revenue (TTM)
$4.08M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+6.4%
Year over year · more shares
Revenue CAGR (3Y)
+9.7%
Revenue CAGR (5Y)
+26.1%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—
Quality
14 metricsReturn on equity
—
Return on assets
-281.8%
Debt / equity
—
Current ratio
0.7
EBITDA (TTM)
—
Free cash flow (TTM)
—
Quick ratio
0.7
Interest coverage
-22.5
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$2.19M
Total assets
$6.67M
Total debt
—
Cash flow & spend
7 metricsOperating cash flow (TTM)
−$10.32M
Capital expenditures (TTM)
—
R&D (TTM)
$3.26M
SG&A (TTM)
$12.63M
Stock compensation (TTM)
$3.28M
R&D / revenue
79.9%
Stock compensation / revenue
80.3%
Ownership (13F)
3 metrics13F filers
1
13F filer change QoQ
0
Institutional ownership
0.0%
Short interest
3 metricsShort interest
0.0%
Latest settlement · 1.0 days to cover
Days to cover
1.0d
Short-squeeze score
26 / 100
Insider activity
2 metricsNet insider buying (90D)
—
Insider-sentiment score
—
Risk flags
1 metricsGoing concern
Flagged